ascopubs.org4 天
Glofitamab in Relapsed/Refractory Mantle Cell Lymphoma: Results From a Phase I/II Study
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org4 天
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose ...
ascopubs.org4 天
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
ascopubs.org4 天
Reply to C. Fuchao et al
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
ascopubs.org4 天
Erratum: CML and the WHO: Why?
The March 20, 2024, article by Berman et al entitled “CML and the WHO: Why?” (J Clin Oncol 10.1200/JCO.23.01689) was published with an error. In the author list ...